I last wrote on Johnson & Johnson (NYSE: JNJ ) stock back in August 2024. In an article titled "Johnson & Johnson: Don't Bet Against Double Compounding ", I argued for a buy As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles per week on such ideas.We have helped our members not only to beat S&P 500 but also avoid heavy drawdowns despit ...